For research use only. Not for therapeutic Use.
TFM-4AS-1 (CAT: I010826) is a potent selective androgen receptor modulator (SARM) that selectively targets the androgen receptor in a tissue-specific manner. By binding to the androgen receptor, TFM-4AS-1 elicits anabolic effects on muscle and bone tissues while minimizing unwanted androgenic effects on other organs. This compound holds promise as a potential therapy for conditions such as muscle wasting disorders, osteoporosis, and androgen deficiency. With its selective action on the androgen receptor, TFM-4AS-1 offers a more targeted approach to modulating androgen signaling, opening up new possibilities for the development of safer and more effective therapies.
| Catalog Number | I010826 |
| CAS Number | 188589-61-9 |
| Synonyms | (1S,3aS,3bS,5aR,9aR,9bS,11aS)-6,9a,11a-Trimethyl-7-oxo-N-[2-(trifluoromethyl)phenyl]-2,3,3a,3b,4,5,5a,9b,10,11-decahydro-1H-indeno[5,4-f]quinoline-1-carboxamide |
| Molecular Formula | C27H33F3N2O2 |
| Purity | ≥95% |
| Target | Androgen Receptor |
| Solubility | Soluble to 10 mM in DMSO and to 10 mM in ethanol |
| Storage | Store at RT |
| IUPAC Name | (1S,3aS,3bS,5aR,9aR,9bS,11aS)-6,9a,11a-trimethyl-7-oxo-N-[2-(trifluoromethyl)phenyl]-2,3,3a,3b,4,5,5a,9b,10,11-decahydro-1H-indeno[5,4-f]quinoline-1-carboxamide |
| InChI | InChI=1S/C27H33F3N2O2/c1-25-14-12-18-16(8-11-22-26(18,2)15-13-23(33)32(22)3)17(25)9-10-20(25)24(34)31-21-7-5-4-6-19(21)27(28,29)30/h4-7,13,15-18,20,22H,8-12,14H2,1-3H3,(H,31,34)/t16-,17-,18-,20+,22+,25-,26+/m0/s1 |
| InChIKey | YFBLEKKYWFJKBP-JZFZSVFHSA-N |
| SMILES | CC12CCC3C(C1CCC2C(=O)NC4=CC=CC=C4C(F)(F)F)CCC5C3(C=CC(=O)N5C)C |
| Reference | <p> |
